Novel Therapies

Keeping pace with an ever-evolving industry

Novel therapies are revolutionizing the treatment of diseases such as cancer, neurological disorders, and various genetically inherited conditions. The production of cell and gene therapies, mRNA vaccines, and anti-sense oligonucleotides, are critical for patients in need to significantly improve or even eliminate their health issues.

We at DPS truly understand the challenges you face with the manufacturing of your advanced therapy medicinal products (ATMP). From expertly designed facilities and regulatory knowledge to constructing a new laboratory facility, or redesigning an existing space for a new therapy, we put your needs first, so that you, in turn, can produce high-quality leading-edge therapies, on time, and within budget. We are here to help you deliver life-changing therapies to your patients.

Many advanced therapeutics companies are at the frontier of this next-generation medicine, harnessing the potential to successfully treat previously untreatable conditions and have entrusted the DPS team to design, construct, and validate their new facilities. 
 

Back to top
DPS Group addresses the COVID-19 pandemic:
A message from Frank Keogh, CEO

Find out more Contact Us